292 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
151 | 9463023 | [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept]. | 1997 Nov | 1 |
152 | 15251771 | Effect of adding a sulfonylurea in patients with non-insulin-dependent diabetes mellitus previously well controlled with insulin. | 1997 Nov-Dec | 2 |
153 | 8773160 | Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects. | 1996 Jan | 1 |
154 | 8842604 | Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. | 1996 Aug | 1 |
155 | 8911981 | The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. | 1996 Sep | 1 |
156 | 8960854 | NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment. | 1996 Dec | 1 |
157 | 9026680 | [Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria]. | 1996 Jun | 1 |
158 | 9072666 | [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months]. | 1996 Sep | 1 |
159 | 7589855 | An ATP-sensitive Cl- channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells. | 1995 Dec | 1 |
160 | 8846678 | More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity. | 1995 Oct | 3 |
161 | 7988301 | Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. | 1994 Sep | 3 |
162 | 8082525 | Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. | 1994 Jun | 2 |
163 | 8112188 | Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months. | 1994 Jan | 3 |
164 | 8123030 | Glyburide enhances insulin gene expression and glucose-induced insulin release in isolated rat islets. | 1994 Feb 28 | 6 |
165 | 8200602 | [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy]. | 1994 Apr 30 | 1 |
166 | 8201916 | [Houssay's phenomenon in man]. | 1993 | 2 |
167 | 8378743 | Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus? | 1993 Jul | 2 |
168 | 8403805 | Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis? | 1993 Sep | 1 |
169 | 8454937 | Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide. | 1993 Apr | 2 |
170 | 8511023 | Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. | 1993 May | 4 |
171 | 1289019 | Morning or bed-time insulin with or without glibenclamide in elderly type 2 diabetic patients unresponsive to oral antidiabetic agents. | 1992 Dec | 1 |
172 | 1547684 | Combination therapy for NIDDM with biosynthetic human insulin and glyburide. | 1992 Feb | 5 |
173 | 1611155 | Treatment of type I diabetes with a combination of glyburide and insulin. | 1992 Jun | 3 |
174 | 1611644 | Glyburide in non-insulin-dependent diabetes: an update. | 1992 Mar-Apr | 4 |
175 | 1628875 | Potassium channels of the insulin-secreting B cell. | 1992 | 1 |
176 | 1660613 | Sulfonylurea signal transduction. | 1991 | 1 |
177 | 1847815 | Glyburide priming of beta cells. Possible involvement of phosphoinositide hydrolysis. | 1991 Mar 1 | 1 |
178 | 1902411 | Comparative effects of diet or glibenclamide on insulin secretion and action in non-obese NIDDM. | 1991 Feb | 1 |
179 | 1904820 | Extrapancreatic insulin effect of glibenclamide. | 1991 | 3 |
180 | 1908182 | Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus. | 1991 Jun 24 | 1 |
181 | 1916009 | Complement activation via the alternative pathway in a patient with insulin-dependent diabetes mellitus. | 1991 Jul-Aug | 1 |
182 | 1954808 | Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. | 1991 Aug | 1 |
183 | 2110711 | Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide. | 1990 Jan-Mar | 1 |
184 | 2115686 | [Insulin-sulfonylurea combination therapy in secondary therapy failure with sulfonylurea compounds. Randomized study between evening and morning intermediary insulin administration using the Novo Pen semi-automatic insulin injector]. | 1990 Jul 10 | 1 |
185 | 2117385 | Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus. | 1990 Aug 20 | 5 |
186 | 2117386 | Effects of glyburide on carbohydrate metabolism and insulin action in the liver. | 1990 Aug 20 | 4 |
187 | 2117387 | Effect of glyburide on hepatic glucose metabolism. | 1990 Aug 20 | 1 |
188 | 2117389 | Effects of glyburide on in vivo insulin-mediated glucose disposal. | 1990 Aug 20 | 3 |
189 | 2119677 | Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide. | 1990 Aug | 1 |
190 | 2122177 | Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. | 1990 Nov | 4 |
191 | 2123183 | Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. | 1990 Aug | 1 |
192 | 2125460 | Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin. | 1990 Nov | 1 |
193 | 2126639 | Combined insulin-glibenclamide therapy of NIDDM patients in primary health care. A follow-up study of its compliance and efficacy and a review of the literature. | 1990 Dec | 1 |
194 | 2171690 | Reduced glucose-6-phosphorylase and NADPH generating enzyme activities associated with glibenclamide induced hypoglycemia and hypoinsulinemia in genetically obese mice. | 1990 | 3 |
195 | 2499443 | Effects of combined insulin-sulfonylurea therapy in type II patients. | 1989 Jun | 1 |
196 | 2504288 | Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. | 1989 Aug 21 | 1 |
197 | 2505990 | Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. | 1989 Sep | 1 |
198 | 2524334 | How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes? | 1989 May-Jun | 3 |
199 | 2559356 | Insulin and IGF-I receptors in neuroblastoma cells: increases in mRNA and binding produced by glyburide. | 1989 Oct | 1 |
200 | 3126291 | A system approach to pharmacodynamics. II: Glyburide pharmacodynamics and estimation of optimal drug delivery. | 1988 Jan | 1 |